Fulgent Genetics, Inc. FLGT Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Fulgent Genetics, Inc. (FLGT) reported cash provided by (used in) operating activity, including discontinued operation of $7.1M in Q1 2026.
- How has Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation increased by 260.2% year-over-year, from -$4.43M to $7.1M.
- What is the long-term trend for Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Over 3 years (2021 to 2024), Fulgent Genetics, Inc.'s cash provided by (used in) operating activity, including discontinued operation has grown at a -66.1% compound annual growth rate (CAGR), from $538.58M to $21.06M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.